RepliCel Life Sciences Inc.

REPCFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$7000

P/E Ratio—

52W High$0.042835

52W Low$0.00001

Avg Volume2K

Open$0.04

Beta0.43

Overview

RepliCel Life Sciences Inc. (REPCF) Revenue

Annual & quarterly revenue history · segment & region breakdown

REPCF · revenue · updated Jun 10, 2026

Core revenue metrics

Trailing 12 months

RepliCel Life Sciences Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

1 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · RepliCel Life Sciences Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

REPCF revenue by year · REPCF revenue history · REPCF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income RepliCel Life Sciences Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

RepliCel Life Sciences Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from RepliCel Life Sciences Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

REPCF revenue · 4 questions

REPCF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

REPCF revenueREPCF annual revenuewhat is REPCF revenueREPCF TTM revenue

▸ Source: FMP · RepliCel Life Sciences Inc. SEC filings · GAAP · RepliCel Life Sciences Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026